March 22, 2024

Abstract 5342: Evaluation of autologous and allogeneic T cell-based therapies in ex-vivo and in-vivo xenograft tumor models

Key Points

Key points are not available for this paper at this time.

Abstract

Abstract The field of adoptive T cell-based immunotherapy, including tumor-infiltrating lymphocytes (TILs), T cell receptor (TCR) Part 1 (Regular Abstracts) ; 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84 (6Suppl): Abstract nr 5342.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Cite this study

Liu et al. (Fri,) studied this question.

www.synapsesocial.com/papers/68e72e32b6db6435876a7aea — DOI: https://doi.org/10.1158/1538-7445.am2024-5342

Authors

Sherry Liu

Jasmine Borroel

Carmen Sunico

Journals

Cancer Research

Actions

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Abstract 5342: Evaluation of autologous and allogeneic T cell-based therapies in ex-vivo and in-vivo xenograft tumor models

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Cite this study

Authors

Journals

Actions

References and Citations

Citation Network

Connected Papers

Discussion